Gene · 5244
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells. | Cancer Chemother Pharmacol | 2024 | 38226983 | PubTator, text mining | PubMed |
| Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells. | Cells | 2024 | 38201302 | PubTator, text mining | PubMed |
| The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7. | Cardiovasc Diabetol | 2024 | 38195542 | PubTator, text mining | PubMed |
| Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis. | JHEP Rep | 2024 | 38192535 | PubTator, text mining | PubMed |
| Maternal and neonatal outcomes of intrahepatic cholestasis of pregnancy after in vitro fertilization. | BMC Pregnancy Childbirth | 2024 | 38191339 | PubTator, text mining | PubMed |
| ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells. | J Exp Clin Cancer Res | 2024 | 38163893 | PubTator, text mining | PubMed |
| Low-dose daily folic acid (400 μg) supplementation does not affect regulation of folate transporters found present throughout the terminal ileum and colon of humans: a randomized clinical trial. | Am J Clin Nutr | 2024 | 38157986 | PubTator, text mining | PubMed |
| Identification of two novel heterodimeric ABC transporters in melanoma: ABCB5β/B6 and ABCB5β/B9. | J Biol Chem | 2024 | 38145744 | PubTator, text mining | PubMed |
| BMP and activin receptor membrane bound inhibitor: BAMBI has multiple roles in gene expression and diseases (Review). | Exp Ther Med | 2024 | 38125356 | PubTator, text mining | PubMed |
| Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts. | Cell Mol Gastroenterol Hepatol | 2024 | 38109970 | PubTator, text mining | PubMed |
| Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells. | Oncol Rep | 2024 | 37975256 | PubTator, text mining | PubMed |
A Prospective Study Measuring Resident and Faculty Contour Concordance: A Potential Tool for Quantitative Assessment of Residents' Performance in Contouring and Target Delineation in Radiation Oncology Residency. | J Am Coll Radiol | 2024 | 37844655 | PubTator, text mining | PubMed |
| Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndrome. | Aliment Pharmacol Ther | 2024 | 37818704 | PubTator, text mining | PubMed |
| A novel heterozygous deletion in ABCB4 gene in a Chinese family with intrahepatic cholestasis of pregnancy, neonatal hyperbilirubinemia, and cholelithiasis: Case reports and literature review. | Mol Genet Genomic Med | 2024 | 37787087 | PubTator, text mining | PubMed |
| The Origin and Fate of Liver Myofibroblasts. | Cell Mol Gastroenterol Hepatol | 2024 | 37743012 | PubTator, text mining | PubMed |
| Clinical, histopathological, and immunohistochemical spectrum of hepatolithiasis: a tertiary care center-based study from north India. | Virchows Arch | 2024 | 37550583 | PubTator, text mining | PubMed |
| Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis. | Hepatology | 2024 | 37535809 | PubTator, text mining | PubMed |
| Phage predation, disease severity and pathogen genetic diversity in cholera patients. | bioRxiv | 2024 | 37398242 | PubTator, text mining | PubMed |
| The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology. | Aging Dis | 2024 | 37307826 | PubTator, text mining | PubMed |
| Early Deregulation of Cholangiocyte NR0B2 During Primary Sclerosing Cholangitis. | Gastro Hep Adv | 2023 | 39130146 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5244/papers?page=9